[go: up one dir, main page]

GT200800117A - Nuevos derivados de furopirimidina aciclicos sustituidos y uso - Google Patents

Nuevos derivados de furopirimidina aciclicos sustituidos y uso

Info

Publication number
GT200800117A
GT200800117A GT200800117A GT200800117A GT200800117A GT 200800117 A GT200800117 A GT 200800117A GT 200800117 A GT200800117 A GT 200800117A GT 200800117 A GT200800117 A GT 200800117A GT 200800117 A GT200800117 A GT 200800117A
Authority
GT
Guatemala
Prior art keywords
furopirimidine
new
aciclic
derivatives substituted
treatment
Prior art date
Application number
GT200800117A
Other languages
English (en)
Inventor
Lampe Thomas
Becker Eva-Maria
Kast Raimund
Beck Hartmut
Jeske Mario
Schuhmacher Joachim
Stoll Friederike
Klein Martina
Akbaba Metin
Knorr Andreas
Stasch Johannes-Peter
Baerfacker Lars
Hillisch Alexander
Karig Gunter
Meininghaus Mark
Schlemmer Karl-Heinz
Schohe-Loop Rudolf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200800117A publication Critical patent/GT200800117A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA PRESENTE SOLICITUD SE REFIERE A NUEVOS DERIVADOS DE FUROPIRIMIDINA ACÍCLICOS SUSTITUIDOS TALES COMO SE MUESTRAN EN LA FIGURA (I), A PROCEDIMIENTOS PARA SU PRODUCCIÓN, A SU USO PARA EL TRATAMIENTO Y/O LA PROFILAXIS DE ENFERMEDADES, ASÍ COMO A SU USO PARA LA PREPARACIÓN DE PRODUCTO MEDICINAL PARA EL TRATAMIENTO Y/O LA PROFILAXIS DE ENFERMEDADES, EN PARTICULAR PARA EL TRATAMIENTO Y/O PROFILAXIS DE ENFERMEDADES CARDIOVASCULARES. T2008
GT200800117A 2005-12-21 2008-06-19 Nuevos derivados de furopirimidina aciclicos sustituidos y uso GT200800117A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005061170A DE102005061170A1 (de) 2005-12-21 2005-12-21 Neue, acyclisch substituierte Furopyrimidin-Derivate und ihre Verwendung

Publications (1)

Publication Number Publication Date
GT200800117A true GT200800117A (es) 2009-12-16

Family

ID=37876878

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200800117A GT200800117A (es) 2005-12-21 2008-06-19 Nuevos derivados de furopirimidina aciclicos sustituidos y uso

Country Status (31)

Country Link
US (1) US8183246B2 (es)
EP (1) EP1966217B1 (es)
JP (1) JP5254032B2 (es)
KR (1) KR101429777B1 (es)
CN (1) CN101384603B (es)
AR (1) AR058108A1 (es)
AU (1) AU2006334856B2 (es)
BR (1) BRPI0620317A2 (es)
CA (1) CA2633701C (es)
CR (1) CR10092A (es)
DE (1) DE102005061170A1 (es)
DK (1) DK1966217T3 (es)
DO (1) DOP2006000280A (es)
EC (1) ECSP088569A (es)
ES (1) ES2418855T3 (es)
GT (1) GT200800117A (es)
IL (1) IL192062A0 (es)
MA (1) MA30039B1 (es)
NO (1) NO20082986L (es)
NZ (1) NZ569214A (es)
PE (1) PE20071168A1 (es)
PL (1) PL1966217T3 (es)
PT (1) PT1966217E (es)
RU (1) RU2454419C2 (es)
SV (1) SV2009002953A (es)
TN (1) TNSN08279A1 (es)
TW (1) TWI405764B (es)
UA (1) UA94080C2 (es)
UY (1) UY30046A1 (es)
WO (1) WO2007079862A1 (es)
ZA (1) ZA200805385B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007019691A1 (de) * 2007-04-26 2008-10-30 Bayer Healthcare Ag Verwendung von acyclisch substituierten Furopyrimidin-Derivaten zur Behandlung der pulmonalen arteriellen Hypertonie
DE102007027799A1 (de) * 2007-06-16 2008-12-18 Bayer Healthcare Ag Substituierte Furopyrimidine und ihre Verwendung
DE102007051762A1 (de) * 2007-10-30 2009-05-07 Bayer Healthcare Ag Substituierte Pyrrolotriazine und ihre Verwendung
DE102007054786A1 (de) * 2007-11-16 2009-05-20 Bayer Healthcare Ag Trisubstituierte Furopyrimidine und ihre Verwendung
JPWO2013168759A1 (ja) 2012-05-10 2016-01-07 武田薬品工業株式会社 芳香環化合物
JPWO2013168760A1 (ja) 2012-05-10 2016-01-07 武田薬品工業株式会社 芳香環化合物
KR102590848B1 (ko) 2016-12-28 2023-10-19 다트 뉴로사이언스, 엘엘씨 Pde2 억제제로서 치환된 피라졸로피리미디논 화합물
ES2902365T3 (es) 2017-11-27 2022-03-28 Dart Neuroscience Llc Compuestos de furanopirimidina sustituidos como inhibidores de PDE1
SG11202111327XA (en) 2019-05-13 2021-11-29 Relay Therapeutics Inc Fgfr inhibitors and methods of use thereof
KR102094337B1 (ko) 2019-10-01 2020-03-27 안문호 금속이물질 제거장치
TW202233625A (zh) 2020-11-18 2022-09-01 美商傳達治療有限公司 Ｆｇｆｒ抑制劑及其製造及使用方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577420A (en) 1968-01-05 1971-05-04 Pfizer Certain 4-aminofuro(2,3-d)pyrimidines
WO2000005234A1 (en) 1998-07-22 2000-02-03 Suntory Limited NF-λB INHIBITORS CONTAINING INDAN DERIVATIVES AS THE ACTIVE INGREDIENT
WO2000075145A1 (en) 1999-06-03 2000-12-14 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
CN1212861C (zh) 1999-09-17 2005-08-03 第一三得利制药株式会社 以NF－κB抑制剂为有效成分的心肌炎、扩张型心肌病和心衰的预防或治疗药
ATE319718T1 (de) 2001-05-14 2006-03-15 Novartis Pharma Gmbh Oxazolo- und furopyrimidine und deren verwendung als medikamente gegen tumore
DE10141212A1 (de) 2001-08-22 2003-03-06 Bayer Ag Neue 4-Aminofuropyrimidine und ihre Verwendung
US7427623B2 (en) 2001-09-11 2008-09-23 Smithkline Beecham Corporation 4-Amino-2,3-disubstituted thieno[2,3-d]pyrimidines and pharmacetical compositions thereof
DE10148883A1 (de) 2001-10-04 2003-04-10 Merck Patent Gmbh Pyrimidinderivate
US20030225098A1 (en) 2002-03-21 2003-12-04 Hirst Gavin C. Kinase inhibitors
KR20050091462A (ko) * 2004-03-12 2005-09-15 한국과학기술연구원 푸로피리미딘 화합물 및 이를 포함하는 ｄｄｒ2 티로신키나아제 활성 저해제
BRPI0511917A (pt) 2004-06-10 2008-01-15 Xention Discovery Ltd composto ou sais farmaceuticamente aceitáveis do mesmo, processo para preparar um composto, composição farmacêutica, método para tratar ou prevenir um distúrbio que requer a inibição do canal de potássio, e, uso de um composto
EP1768986A2 (en) * 2004-06-29 2007-04-04 Amgen Inc. Furanopyrimidines

Also Published As

Publication number Publication date
US8183246B2 (en) 2012-05-22
RU2008129363A (ru) 2010-01-27
JP5254032B2 (ja) 2013-08-07
UA94080C2 (ru) 2011-04-11
CA2633701C (en) 2014-05-27
KR101429777B1 (ko) 2014-08-19
EP1966217A1 (de) 2008-09-10
DOP2006000280A (es) 2007-07-31
CA2633701A1 (en) 2007-07-19
MA30039B1 (fr) 2008-12-01
EP1966217B1 (de) 2013-05-08
TW200745132A (en) 2007-12-16
AR058108A1 (es) 2008-01-23
HK1130054A1 (en) 2009-12-18
WO2007079862A1 (de) 2007-07-19
NZ569214A (en) 2011-07-29
PT1966217E (pt) 2013-07-12
TWI405764B (zh) 2013-08-21
IL192062A0 (en) 2008-12-29
ECSP088569A (es) 2008-08-29
CR10092A (es) 2008-10-08
ZA200805385B (en) 2009-10-28
KR20080081323A (ko) 2008-09-09
PE20071168A1 (es) 2008-02-07
NO20082986L (no) 2008-07-02
CN101384603A (zh) 2009-03-11
ES2418855T3 (es) 2013-08-16
JP2009520713A (ja) 2009-05-28
PL1966217T3 (pl) 2013-09-30
AU2006334856A1 (en) 2007-07-19
US20090318475A1 (en) 2009-12-24
TNSN08279A1 (en) 2009-10-30
SV2009002953A (es) 2009-04-28
UY30046A1 (es) 2007-07-31
DK1966217T3 (da) 2013-08-05
AU2006334856B2 (en) 2013-04-04
RU2454419C2 (ru) 2012-06-27
CN101384603B (zh) 2012-08-01
DE102005061170A1 (de) 2007-07-05
BRPI0620317A2 (pt) 2011-11-08

Similar Documents

Publication Publication Date Title
GT200800117A (es) Nuevos derivados de furopirimidina aciclicos sustituidos y uso
ECSP12012125A (es) Ariltriazolonas ligadas a bisarilo y su uso
HN2011002406A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
ECSP077296A (es) Fenilaminotiazoles sustituidos y su uso
UY31228A1 (es) Ariloxazoles sustituidos y su uso
DOP2009000205A (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y su uso
UY27878A1 (es) Derivados de indolinfenilsulfonamida
CR20140096A (es) Pirimidinas anilladas sustituidas y uso de las mismas
DOP2007000043A (es) Derivados de cromanol sustituidos y su uso
UY35693A (es) Pirazolo[1,5-a]piridin-3-carboxamidas sustituidas y su uso
UY32052A (es) 5-aminopirazoles sustituidos y uso de los mismos
AR058098A1 (es) Derivados de acidos dicarboxilicos y su uso
ECSP088472A (es) Derivados de 9-cloro-15-desoxiprostaglandina, procesos para su preparación y su uso como medicamento
DOP2006000062A (es) Derivados de acido pirimidincarboxilico y su uso
CR11869A (es) 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos
GT200500266A (es) Nuevos derivados de pirimidina y su uso
DOP2005000250A (es) Amidas de acido pirazindicarboxilico y su uso
CU23704B7 (es) Nuevos derivados de furopirimidina acíclicos sustituidos y su uso
HN2008000946A (es) Nuevos derivados de furopirimidina aciclicos sustituidos
DOP2005000174A (es) Fenilaminotiazoles sustituidos y su uso
DOP2003000663A (es) Derivados de indolinfenilsulfonamida
UY29247A1 (es) Amidas de ácido pirazindicarboxílico y su uso
CR20120445A (es) Ariltriazolonas ligadas a bisarilo y su uso
CU20100260A7 (es) 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos